Ligand · MJN
MJN · N-[(2R)-1-(methylamino)-3-{1-[(4-methyl-2-oxo-1,2-dihydroquinolin-6-yl)acetyl]piperidin-4-yl}-1-oxopropan-2-yl]-5-phenylpyridine-2-carboxamide
MJN, N-[(2R)-1-(methylamino)-3-{1-[(4-methyl-2-oxo-1,2-dihydroquinolin-6-yl)acetyl]piperidin-4-yl}-1-oxopropan-2-yl]-5-phenylpyridine-2-carboxamide (C33 H35 N5 O4, 565.7 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1…
- Component
- MJN
- Formula
- C33 H35 N5 O4
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
MJN in 2 structures; the first of them:
- 7UBO · Crystal Structure of the first bromodomain of human BRDT in complex with the inhibitor… · MJN A201 · binds PHE48, TRP50, PRO51, VAL56, LEU61, LEU63, TYR66, CYS105 and 12 more
- 7UBO · Crystal structure of the first bromodomain of human brdt in complex with the inhibitor… · MJN A201 · binds PHE48, TRP50, PRO51, VAL56, LEU61, LEU63, TYR66, ASN109 and 8 more
Residues it binds most
LEU 8, TYR 8, PRO 8, ASN 8, ASP 8, ILE 8, MET 8, VAL 8, PHE 8, TRP 8 (residue and the binding sites it lines).
Found with
- DMS · Dimethyl sulfoxide
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.